IMU Biosciences raises £11.5 million Series A

We are delighted to announce that Molten Ventures has led a £11.5 million Series A funding round in IMU Biosciences, a techbio company revolutionising immune powered precision medicine.
IMU...

Related Keywords

Boston ,Massachusetts ,United States ,London ,City Of ,United Kingdom ,Cambridge ,Cambridgeshire ,Tim Haines ,Oliver Nussbaumer ,Adrian Hayday ,Mario Cantero ,Inga Deakin ,Adam Laing ,Adaptate Biotherapeutics ,Tom Hayday ,King College London ,Duke University ,Francis Crick Institute ,Non Executive Chair ,Executive Partner ,Executive Scientific Director ,Cell Therapy Innovations ,Delta Therapeutics ,Chief Executive Officer ,Chief Scientific Officer ,Chief Operating Officer ,College London ,Markets ,